Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies. (Q33393992)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

based on heuristic

inferred from title

Johanna A Kremer Hovinga

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

B Plaimauer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C Juno

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M J Wolfsegger

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

S Skalicky

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Schmidt

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

L Grillberger

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Hasslacher

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

P Knöbl

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

H Ehrlich

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

F Scheiflinger

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

936-944

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294825%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Thrombotic Microangiopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Genetic defects leading to hereditary thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Treatment of Thrombotic Thrombocytopenic Purpura with Plasma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Immunotherapy for thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Expression and characterization of recombinant human ADAMTS-13

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04224.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33393992&oldid=1971918464"